CareDx Update Regarding Raymond James & Associates’ Conference

Rhea-AI Summary

CareDx, Inc. (NASDAQ: CDNA) announced it will not participate in the Raymond James & Associates' 44th Annual Institutional Investors Conference due to scheduling conflicts. The Company is focused on providing high-value healthcare solutions for transplant patients and their caregivers. CareDx specializes in precision medicine, offering testing services and digital healthcare solutions throughout the transplant journey. The Company looks forward to releasing its next corporate update soon, indicating ongoing engagement with investors and stakeholders.

Positive

• Focus on high-value healthcare solutions for transplant patients.
• Strong positioning in precision medicine and genomics-based information.

Negative

• Non-participation in a significant investor conference may raise concerns regarding investor engagement.

BRISBANE, Calif.--(BUSINESS WIRE)-- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the Company has determined not to participate in the Raymond James & Associates’ 44^th Annual Institutional Investors Conference scheduled for later today in light of scheduling conflicts. The company looks forward to providing its next corporate update in the near term.

About CareDx – The Transplant Company

CareDx, Inc., headquartered in Brisbane, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230306005824/en/

CareDx, Inc.

Investor Relations

Greg Chodaczek

investor@CareDx.com

Source: CareDx, Inc.

FAQ

Why is CareDx not participating in the Raymond James & Associates' conference?

CareDx is not participating due to scheduling conflicts.

What is the stock symbol for CareDx?

The stock symbol for CareDx is CDNA.

What does CareDx focus on?

CareDx focuses on healthcare solutions for transplant patients and caregivers.

When can investors expect the next update from CareDx?

CareDx plans to provide its next corporate update in the near term.